Search

Start typing to see results...

  • Home
  • >
  • Stock Market
  • >
  • Bliss Gvs Pharma Ltd

Bliss Gvs Pharma Ltd share price and stock overview

Bliss Gvs Pharma Ltd (NSE: BLISSGVS, BSE: 506197) operates in the Pharmaceuticals - Indian - Formulations sector. The stock has an ISIN of INE416D01022 and a face value of Rs 1. As of 28 September 2026, it trades at Rs (739.90) with a market capitalisation of Rs 7542.02 crore. Figures are live and subject to change.

Bliss Gvs Pharma Ltd

Pharmaceuticals - Indian - Formulations
NSE BSE
739.90 35.20 (5.00%) upARrowC
As on: 28-Sep-2026 , 10:29 AM
Market Cap(₹Cr) 7542.02
Book Value(₹Cr) 108.6464045
BSE Code : 506197 NSE Symbol : BLISSGVS EPS(TTM) : 10.9 ISIN Demat : INE416D01022 P/E(TTM) : 65.07 Face Value(₹) : 1 Div & Yield % : 0.14

Today Market

Stock Performance

Today Market

Today's High

73,740.85

Todday's Low

72,921.75

Open at

73,734.83

Previous Close

73,895.74

Volumes

0.00

Avg Price

-953.11

Historical Performance

News

04 Sep 26
Bliss GVS Pharma allots equity shares to employees under its 2019 Employee Stock Option Plan
Bliss GVS Pharma Limited announced the allotment of 55,250 equity shares with a face value of Re.
11 Aug 26
Bliss GVS Pharma Limited’s committee approved allotment of equity shares to employees
Bliss GVS Pharma Limited announced that its ESOP Allotment Committee approved the allotment of 31,250 equity shares to eligible employees under the Bliss GVS Pharma Limited – Employee Stock Option Plan 2019, increasing the company’s issued, subscribed, and paid-up share capital from 10,62,43,973 equity shares aggregating Rs 10,62,43,973 to 10,62,75,222 equity shares aggregating Rs 10,62,75,222.
05 Aug 26
Bliss GVS Pharma to review quarterly financial results at board meeting August 12
Bliss GVS Pharma Limited will hold a board meeting on Wednesday, August 12, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, according to a regulatory filing.
13 May 26
Bliss GVS Pharma AGM scheduled
Bliss GVS Pharma announced that the 41th Annual General Meeting(AGM) of the company will be held on 15 July 2026.

Historical Prices

Share Price Chart

Historical Share Price

From Date:
To Date:     
Date Open Price (₹) High Price(₹) Low Price(₹) Close Price(₹) Total Volume No of Trades Net Turnover(₹) NIFTY
25-09-26 685.10 715.00 670.00 704.70 433524 3909 305179935.15 23140.50
24-09-26 707.75 707.75 680.00 687.05 159514 1670 109470938.10 23063.10
23-09-26 684.00 717.00 681.05 699.20 152263 2010 107208366.35 23446.80
22-09-26 661.55 694.60 651.55 694.60 353104 3759 243585986.05 23329.00
21-09-26 680.00 705.00 660.00 661.55 186811 2557 124604840.70 23414.30
18-09-26 690.75 701.00 675.00 681.85 168694 2418 115959306.55 23346.40
17-09-26 680.00 698.90 680.00 690.65 198123 2368 136868805.60 23270.60
16-09-26 676.40 685.30 650.75 680.50 412619 3395 272327064.15 23217.60
15-09-26 719.00 728.00 684.95 684.95 217584 3557 150980287.20 23118.60
11-09-26 698.00 724.00 676.00 720.95 190726 3124 134185271.90 23398.10
123...

Fundamentals

Company Valuation

Market Cap (₹cr)

7542.02

PE Ratio

65.07

PB Ratio

6.53

Dividend Yield

0.14

ROE

8.75

ROCE

12.51

Book Value (₹)

108.6464045

Face Value (₹)

1

Share Holding Pattern

Category of Shareholder No of Shares % Share Holdings Demat Shares Share Holders
plus  Promoter & Group
plus  Foreign
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
plus  Indian
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 37130124 35.01 37130124 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 37130124 35.01 37130124 5
Total ShareHolding for Promoter & Group 37130124 35.01 37130124 5
plus   Publice Share Holding
plus  Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 8562026 8.07 8562026 44
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 3440388 3.24 3440388 1
Mutual Funds / UTI 272014 0.26 272014 3
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 6327739 5.97 6327739 13
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 18602167 17.54 18602167 61
plus  Non Institution
Bodies Corporate 10282077 9.69 10256677 261
Clearing Members 238541 0.22 238541 32
Directors & their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1190067 1.12 1119467 821
Foreign Non Institution Other 200 0.00 200 1
Hindu Undivided Families 2438438 2.30 2438438 793
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 11914135 11.23 11914135 11
Individuals holding nominal share capital up to Rs. 1 lakh 19659079 18.54 18570977 44725
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 11600 0.01 11600 1
Others 2665407 2.51 2665407 3
Sub Total 50323931 47.45 49121769 46701
Total Public Shareholding 68926098 64.99 67723936 46762
Total of Promoter & Public ShareHolding 106056222 100.00 104854060 46767
plus  Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total 106056222 100.00 104854060 46767

Financials (₹ in cr)

Consolidated Standalone
Year EndMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Net Sales927.11809.73770.24751.59747.45
OPM (%)20.7215.5218.9614.1117.09
OP192.08125.64146.07106.07127.76
Other Income73.5336.4928.7417.7931.49
PBIDT235.08163.18150.16135.1176.24
INTEREST12.018.126.9110.364.74
PBDT223.07155.06143.25124.7471.50
PBT187.10125.6487.68106.07-19.43
EO-2.490.00-29.200.00-73.59
PBT after EO189.59125.64116.87106.0754.17
TAXES54.8635.3835.2929.3431.04
PAT129.1384.3075.4570.8615.04
EPS12.007.957.116.721.43
Raw Material41.6646.0044.0343.9151.54
Power and Fuel1.531.401.350.951.10
Employee Cost14.7213.8412.4111.4610.19
Other Manufacturing Expenses0.000.000.000.000.00
Selling and Administration Expenses13.1111.6511.1510.7010.79
Miscellaneous Expenses4.644.303.516.257.95
Revenue (Growth %) 14.505.132.480.5529.50
PBIDT (Growth %)44.068.6711.1477.22-39.91
PAT (Growth %) 53.1811.726.49371.13-78.04
PBIDT (Margin %)25.3620.1519.5017.9810.20
PAT (Margin %) 13.9310.419.809.432.01

Balance Sheet (₹ in cr)

Particulars (Sources Of Funds)Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Share Capital 10.5810.5410.4710.4210.3710.31
Reserves Total 1144.611048.10977.94926.58841.06745.33
Equity Share Warrants0.000.000.000.000.000.00
Equity Application Money0.000.000.040.000.000.00
Total Shareholders Funds1155.191058.64988.45937.00851.43755.64
Secured Loans 0.0023.1045.8365.7164.6967.87
Unsecured Loans 13.2344.6231.6714.8625.2223.97
Total Debt13.2367.7277.5080.5789.9191.84
Other Liabilities11.384.362.602.611.072.50
Total Liabilities1179.801130.721068.551020.18942.41849.98
APPLICATION OF FUNDS :
Gross Block 555.24478.42414.15385.72270.23211.63
Less : Accumulated Depreciation 135.01109.8583.5160.2245.2336.85
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 420.23368.57330.64325.50225.00174.78
Lease Adjustment0.000.000.000.000.000.00
Capital Work in Progress4.4020.587.832.8022.152.39
Producing Properties0.000.000.000.000.000.00
Investments 18.6918.6918.6918.2618.2618.30
Current Assets, Loans & Advances
Inventories 110.9281.9489.4574.1590.1183.68
Sundry Debtors 457.12428.70399.51399.06408.82348.68
Cash and Bank Balance110.60171.11169.3284.61149.48119.52
Loans and Advances 147.7283.99113.96171.83143.32124.77
Total Current Assets826.36765.74772.24729.65791.74676.65
Less : Current Liabilities and Provisions
Current Liabilities 155.6688.9381.18114.30124.9487.00
Provisions 8.720.490.541.744.691.59
Total Current Liabilities & Provisions164.3889.4281.72116.03129.6288.59
Net Current Assets661.98676.32690.52613.62662.12588.06
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets41.7032.0324.3213.645.013.59
Deferred Tax Liability26.6022.9420.2117.1212.9310.64
Net Deferred Tax15.109.094.11-3.48-7.92-7.05
Other Assets59.4137.4716.7763.4822.8173.50
Total Assets1179.801130.721068.561020.18942.43849.99
Contingent Liabilities10.714.656.182.631.4114.96

Cash Flow (₹ in cr)

Yearly Cash FlowMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Financing Activities -12.62-26.05-20.76-26.56-75.37
Investing Activities -92.28-12.97-65.84-77.97-51.30
Net Cash Flow 9.144.79-4.43-7.32-3.52
Operating Activities 114.0543.8182.1797.21123.16

Peers

Balance Sheet Financial Ratios Profit & Loss
Accretion Nutrav...

Adline Chem Lab ...

Ajanta Pharma Lt...

3,540.80

(-0.20%)
Amrutanjan Healt...

509.00

(+0.52%)
Bafna Pharmaceut...

357.05

(+2.00%)
BDH Industries L...

Bharat Immunolog...

Bharat Parentera...

2,180.00

(+14.86%)

Corporate Actions

Bonus Dividends Splits
DateCorporate ActionInformation
No Corporate Actions Announced

Board of Directors

Chairman & Chief Executive Officer
NKC
Nandkumar Kashinath Chodankar
Chairman & Independent Directo
Executive
Independent Directors
SB
Shilpa Bhatia
Independent Non Executive Women Director
Ind.
VM
Vijayanarayanan Mahadevan
Independent Non Exe. Director
Ind.
DRS
Deepak Rameshchandra Shah
Independent Non Exe. Director
Ind.
Company Secretary & Compliance
AB
Aditi Bhatt
Company Secretary
Sec.
Other Officials
SNK
Shibroor N Kamath
ED / MD / CEO / Promoter
Board

Frequently Asked Questions

What is the NSE symbol and BSE code for Bliss Gvs Pharma Ltd? −

Bliss Gvs Pharma Ltd trades on NSE under BLISSGVS and on BSE under code 506197. The ISIN is INE416D01022 and the face value is Rs 1.

What is the share price of Bliss Gvs Pharma Ltd today? +

As of 28 September 2026, Bliss Gvs Pharma Ltd trades at Rs 739.90, a change of 35.20 (5.00%) on the day. Prices are live and subject to change.

What is the market capitalisation of Bliss Gvs Pharma Ltd? +

As of 28 September 2026, Bliss Gvs Pharma Ltd has a market cap of about Rs 7542.02 crore. This figure is live and moves with the share price.

Is Bliss Gvs Pharma Ltd profitable? +

In March 2026, Bliss Gvs Pharma Ltd reported a profit after tax of Rs 129.13 crore. The wording switches to "a net loss of Rs X crore" when the figure is negative.

What is the PE ratio of Bliss Gvs Pharma Ltd? +

: As of 28 September 2026, the PE (TTM) for Bliss Gvs Pharma Ltd is 65.07 and the price-to-book ratio is 6.53. When the PE shows zero, state that PE TTM is currently not applicable and give the PB only.

Does Bliss Gvs Pharma Ltd pay a dividend? +

As of 28 September 2026, the dividend yield for Bliss Gvs Pharma Ltd is 0.14%. The wording switches to "does not currently pay a dividend" when the yield is zero.

What is the shareholding pattern of Bliss Gvs Pharma Ltd? +

As of the latest disclosed pattern, promoters hold 35.01% of Bliss Gvs Pharma Ltd. Public shareholding is 64.99%, including mutual funds at 0.26% and foreign institutional investors at 8.07%.

What were the latest annual financials of Bliss Gvs Pharma Ltd? +

In March 2026, Bliss Gvs Pharma Ltd reported net sales of Rs 927.11 crore, revenue growth of 14.50%, and earnings per share of Rs 12.00.